Vaccination

Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial
Stefan Andreas, Marco Testa, Laurent Boyer, Guy Brusselle, Wim Janssens, Edward Kerwin, Alberto Papi, Bonavuth Pek, Luis Puente-Maestu, Dinesh Saralaya, Henrik Watz, Tom Ma Wilkinson, Daniela Casula, Gennaro Di Maro, Maria Lattanzi, Luca Moraschini, Sonia Schoonbroodt, Annaelisa Tasciotti, Ashwani K Arora, François Maltais

European Respiratory Journal Sep 2021, 58 (suppl 65) RCT210; DOI: 10.1183/13993003.congress-2021.RCT210
RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations
Laura Conejero Hall, Luis Puente Maestu, Myriam Calle Rubio, Walter Girón, Carlos José Alvarez Martínez, María Jesús Buendía García, Joan Serra Batllés, Juan Luis Rodríguez Hermosa, Soledad Alonso Viteri, Julia García De Pedro, Paola Benedetti, Javier De Miguel Díez, José Luis Alvarez-Sala Walther, Julio Hernández Vázquez, Francisco García Río, Carmen Rodríguez Sainz, Cristina Fernández Pérez, Ana Doyle, Raquel Caballero, José Luis Subiza, Miguel Casanovas, Eduardo Fernández-Cruz

European Respiratory Journal Sep 2021, 58 (suppl 65) RCT207; DOI: 10.1183/13993003.congress-2021.RCT207
Late Breaking Abstract - COVID-19 risk perception and vaccine willingness among healthcare workers in specialized respiratory clinics in Germany
Maria Ada Presotto, Rudolf A. Jörres, Wolfgang Gesierich, Jörn Bullwinkel, Klaus Rabe, Konrad Schultz, Franziska Kaestner, Dominik Harzheim, Michael Kreuter, Felix.J.F. Herth, Franziska Trudzinski

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3891; DOI: 10.1183/13993003.congress-2021.PA3891
Acceptability of healthcare professionals to get vaccinated against COVID-19 two weeks before initiation of national vaccination in Greece
Athanasia Pataka, Seraphim Kotoulas, Emilia Stefanidou, Ioanna Grigoriou, Ioanna Tsiouprou, Paraskevi Argyropoulou

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3561; DOI: 10.1183/13993003.congress-2021.PA3561
Influenza and Pneumococcal vaccination effects on the immune-related adverse events in patients under immunotherapy for an advanced stage non-small cell lung cancer
Mathilde MONBRUN, Léo Grassion, Elodie Blanchard, Rémi Veillon, Maeva Zysman, Chantal Raherison

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2303; DOI: 10.1183/13993003.congress-2021.PA2303
Parents' attitude towards seasonal vaccination of children against an influenza virus
Roman Bontsevich, Alina Mikhno, Zhanna Zhdanova, Darya Kutsenko, Ann Adonina

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3147; DOI: 10.1183/13993003.congress-2021.PA3147
Influenza vaccination in children with high-risk chronic diseases
Elpis Hatziagorou, Evangelia Argyropoulou, Alexandra Soldatou, John Tsanakas

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3146; DOI: 10.1183/13993003.congress-2021.PA3146
Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough
Moataz Elashmawy, James Baker, Theofilos Polychronakis

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3150; DOI: 10.1183/13993003.congress-2021.PA3150
The Impact of Conjugated Pneumococcal Vaccine on Exacerbation Frequency in Patients with COPD
Zeynep Öndeş, Yelda Varol, Ali Kadri Cirak, Burcin Hakoglu, Serpil Tekgul

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2139; DOI: 10.1183/13993003.congress-2021.PA2139
Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis
Elena Blinova, Galina Ignatova

European Respiratory Journal Sep 2021, 58 (suppl 65) PA2014; DOI: 10.1183/13993003.congress-2021.PA2014

Main menu

User menu

Search

Vaccination

Pages

Contact us